alr technologies inc (ALRT) Key Developments
ALR Technologies Announces Partnership With My Diabetes Home
Nov 14 13
ALR Technologies announced that My Diabetes Home is offering its registered users access to an ALRT-developed electronic logbook to track their blood glucose numbers. This electronic logbook will provide added convenience by allowing patients to upload their blood glucose results from their meter directly into an online spreadsheet. With this technology, patients no longer need to make individual test result entries manually. The uploaded data can be saved online, emailed or faxed to a provider, or printed and brought to a physician visit.
ALR Technologies Deleted From OTCBB
Jul 18 13
ALR Technologies, Inc.'s common stock will be deleted from OTC Bulletin Board effective July 18, 2013 on account of ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.
ALR Technologies Inc. Announces Change of Auditors
Apr 23 13
On April 9, 2013, ALR Technologies Inc. terminated Anton & Chia LLP, 440 MacArthur Blvd, Suite 970, Newport Beach, CA 92660, as its independent registered public accounting firm. On April 9, 2013, the company engaged Dale Matheson Carr-Hilton LaBonte LLP (DMCL), 1140 West Pender Street, Suite 1500, Vancouver, BC, V6E 4G1, Canada, an independent registered public accounting firm, as its principal independent accountant with the recommendation of the company's Audit Committee and approval of the company's Board of Directors.
ALR Technologies Inc. Announces Board Appointments
Apr 22 13
On April 19, 2013, the ALR Technologies Inc. approving the election of Sidney Chan, Lawrence Weinstein, Dr. Alfonso Salas, Kenneth Robulak and William Smith to board of directors. Mr. Chan joined ALR Technologies Inc. in August 1997. He has been instrumental in the Company’s financing, product development, corporate development. Mr. Chan has led the Company’s product development of the Health-E-Connect. Mr. Chan possesses in-depth knowledge of the equity markets and investment industry, as well as a strong fundamental background in the responsibilities of corporate development and operations. Mr. Weinstein joined ALRT in July 2010, bringing over 25 years of medical device development and management experience from organizations such as Cordis Corporation, DHD Healthcare and PARI Respiratory Equipment. Mr. Weinstein has extensive experience in the development and launch of medical products, including obtaining FDA approval for product lines and developing extensive quality control systems to ensure on-going regulatory compliance. Prior to working with ALRT, Mr. Weinstein had spent nine years working with Pari Respiratory Inc. in Midlothian, Virigina, achieving the position of Senior Vice President of Operations. Pari Respiratory is worldwide private company engages in the
design, manufacture, and distribution of aerosol delivery products for patients with respiratory diseases, such as asthma, chronic lung diseases, and cystic fibrosis. Dr. Salas began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in 1984. He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in 1991 doing medical assessments for work related accidents. In 1993 Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since 1995 Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations with a focus on budgeting, research and medical services. From December 14, 1999 to January 31, 2001, Mr. Robulak was a member of board of directors and from April 4, 2000 to January 31, 2001 Mr. Robulak was chief financial officer, secretary, treasurer and vice president. Mr. Robulak resigned as an officer and director on January 31, 2001. At the time of his resignation, Mr. Robulak did not have any disagreements with us relating to operations, policies, or practices. Since August 2005, Mr. Robulak has served as a Director of Belle Harbor Owners Association. Since July 2007, Mr. Robulak has worked as a marketing consultant to Teco Metal Products, LLC. Mr. Smith is a healthcare and government relations professional with 25 years’ experience with both private companies and departments of federal and state Government. From September 2010 to December 2012, Mr. Smith was the Managing Director of the Healthcare Division at NSI. From November 2009 to August 2010, Mr. Smith was a consultant and an advisor to the Charlie Baker Campaign for Governor for the state of Massachusetts. From January 2003 to October 2009, Mr. Smith was the Vice President, US Public Affairs and Policy, at Pfizer Inc. in New York City where he developed US policy based commercial strategies with the Pfizer business unit leaders.
ALR Technologies Inc. Appoints James R. Gavin III as Senior Medical Consultant
Apr 10 13
ALR Technologies Inc. announced that Dr. James R. Gavin III, MD, PhD, has been appointed Senior Medical Consultant for the company. As Senior Medical Consultant, Dr. Gavin will provide strategic advice on clinical aspects of the company's operations with a particular focus on the company's Health-e-Connect Diabetes Management Program. That program allows for the remote monitoring of patients' blood glucose levels combined with a robust care facilitation capability. Dr. Gavin will also provide strategic input on working with health care payers and providers based on his extensive network of medical colleagues. As one of the world's leading diabetes clinicians, Dr. Gavin's expertise will be invaluable in guiding the commercial launch of the ALRT Program. ALRT's Health-e-Connect Diabetes Management Program focuses on the right level of monitoring combined with helpful and constructive communication with patients, providers and caregivers. Dr. Gavin has devoted his career to this type of front line diabetes care. Dr. Gavin currently serves as CEO and Chief Medical Officer of Healing Our Village, Inc, Clinical Professor of Medicine at Emory University School of Medicine, and Clinical Professor of Medicine at Indiana University School of Medicine. Dr. Gavin is a former president of the American Diabetes Association. Prior to this, he was president of the Morehouse School of Medicine in Atlanta from 2002-2004. He served as senior scientific officer at the Howard Hughes Medical Institute (HHMI) from 1991 to 2002 and as director of the HHMI-National Institutes of Health Research Scholars Program from 2000 to 2002. Before joining the senior staff of HHMI, Dr. Gavin was professor and chief of the Diabetes Section, acting chief of the Section on Endocrinology, Metabolism, and Hypertension, and William K. Warren Professor for Diabetes Studies at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. He previously served as an associate professor of medicine at Washington University School of Medicine in St. Louis, Missouri. Dr. Gavin served as a lieutenant commander in the US Public Health Service from 1971 to 1973 and continues to serve as a reserve officer.